CN117362307A - Preparation method and application of bergenia plant active ingredient - Google Patents

Preparation method and application of bergenia plant active ingredient Download PDF

Info

Publication number
CN117362307A
CN117362307A CN202311059234.9A CN202311059234A CN117362307A CN 117362307 A CN117362307 A CN 117362307A CN 202311059234 A CN202311059234 A CN 202311059234A CN 117362307 A CN117362307 A CN 117362307A
Authority
CN
China
Prior art keywords
way valve
separation
bergenia
active ingredient
phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202311059234.9A
Other languages
Chinese (zh)
Inventor
李金萍
沙希德·阿齐兹
希达悦·侯赛因
王岱杰
吉奥范尼·阿彭迪诺
崔莉
朴政一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qilu University of Technology
Original Assignee
Qilu University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qilu University of Technology filed Critical Qilu University of Technology
Priority to CN202311059234.9A priority Critical patent/CN117362307A/en
Publication of CN117362307A publication Critical patent/CN117362307A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/47Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/40Separation, e.g. from natural material; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • C07H1/08Separation; Purification from natural products
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06Benzopyran radicals
    • C07H17/065Benzo[b]pyrans
    • C07H17/07Benzo[b]pyran-4-ones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention relates to the technical field of plant extraction, in particular to a preparation method and application of bergenia plant active ingredients, wherein the preparation method comprises the following steps: crude extract preparation, selection of biphasic solvent system, solvent system and sample solution preparationAnd high-speed countercurrent chromatographic separation. The present invention allows for the isolation of compounds from the rhizome of schefflera arboricola by establishing an efficient one-step internal recycle CCC process. The invention adopts an optimized biphasic solvent system to successfully separate five compounds of quercetin-rhamnoside, quercetin-3-O-rhamnoside, bergenin, kaempferol and palmitic acid, and the purity is equal>98%, the established one-step inner loop CCC method is applicable to the method with similar K D The separation of the compound has the advantages of less solvent consumption, short time consumption, high theoretical polar plate number and the like.

Description

一种岩白菜属植物活性成分的制备方法及应用Preparation method and application of active ingredients of cabbage plants

技术领域Technical field

本发明涉及植物提取技术领域,具体地涉及一种岩白菜属植物活性成分的制备方法及应用。The present invention relates to the technical field of plant extraction, and specifically relates to a preparation method and application of active ingredients of cabbage plants.

背景技术Background technique

岩七为岩白菜属植物,是一种著名的药用植物,被用于治疗不同的疾病,如糖尿病、腹泻、呕吐、咳嗽、发烧、伤口愈合、肺部疾病和癌症等。其中,3-O-Galloylepicatechin和3-O-galloylcatechin这两种化合物是从岩七甲醇提取物中分离得到的,它们对大鼠肠道α-糖苷酶和猪胰腺α-淀粉酶活性的抑制具有较强的剂量依赖性。岩七的药物作用与其大量的有效成分有关,可采用硅胶凝胶胶LH-20和高效液相色谱法对其有效成分进行分离。然而,其结构的相似性及高极性,使得从岩七的根茎中分离各种组分仍是一个很大的挑战。Rock seven, a plant of the genus Lithops, is a famous medicinal plant used to treat different diseases such as diabetes, diarrhea, vomiting, cough, fever, wound healing, lung diseases and cancer. Among them, 3-O-Galloylepicatechin and 3-O-galloylcatechin are two compounds isolated from the methanol extract of Pangasius. They have inhibitory effects on the activity of rat intestinal α-glucosidase and pig pancreatic α-amylase. Strong dose dependence. The medicinal effect of Pangasius is related to its large number of active ingredients, and its active ingredients can be separated using silica gel LH-20 and high-performance liquid chromatography. However, its structural similarity and high polarity make it still a big challenge to separate various components from the rhizomes of Pangasius.

发明内容Contents of the invention

本发明的目的在于克服现有技术存在的缺点,提出设计一种岩白菜属植物活性成分的制备方法,采用高效的一步内循环逆流色谱法制备、分离和纯化岩七中具有相似分配系数的化合物。The purpose of the present invention is to overcome the shortcomings of the existing technology and propose a method for preparing the active ingredients of rock cabbage plants, using an efficient one-step internal circulation countercurrent chromatography method to prepare, separate and purify compounds with similar distribution coefficients in rock seven. .

本发明解决其技术问题所采取的技术方案是:The technical solutions adopted by the present invention to solve the technical problems are:

一种岩白菜属植物活性成分的制备方法,包括:A method for preparing active ingredients of cabbage plants, including:

步骤1、粗提物制备:取岩七根茎,采用甲醇提取,将提取液合并、浓缩,得岩七的甲醇粗提物;Step 1. Preparation of crude extract: Take the rhizome of Pangasius, extract it with methanol, combine the extracts and concentrate to obtain the methanol crude extract of Pangasius;

步骤2、双相溶剂体系的选择:取甲醇粗提物样品放入容器中,加入平衡后的双相溶剂,反复震荡,使样品完全分布在两相中,静置分为两层,每相加入甲醇稀释;通过将下相-固定相AL的目标化合物峰面积除以上相-流动相AU的峰面积来计算KD值:KD=AL/AUStep 2. Selection of biphasic solvent system: Put the crude methanol extract sample into a container, add the balanced biphasic solvent, and shake repeatedly to make the sample completely distributed in the two phases. Let it stand and divide into two layers. Add methanol to dilute; calculate the K D value by dividing the peak area of the target compound in the lower phase - stationary phase A L by the peak area of the upper phase - mobile phase A U : K D = A L / AU ;

步骤3、溶剂系统和样品溶液制备Step 3. Solvent system and sample solution preparation

HSCCC分离准备:在分液漏斗中加入含TBME-正丁醇-乙腈-水的双相溶剂体系并对其进行剧烈震荡,静置至成两相平衡状态,上下相分别作为固定相和流动相;Preparation for HSCCC separation: Add a biphasic solvent system containing TBME-n-butanol-acetonitrile-water to the separatory funnel and shake it vigorously, then let it stand until it reaches a two-phase equilibrium state. The upper and lower phases serve as stationary phase and mobile phase respectively. ;

样品溶液准备过程:将岩七提取物加入容器中,分别加入TMBE-正丁醇-乙腈-水溶剂体系的上相和下相,使样品完全溶解;作为优选,加入的岩七提取物与容器体积比为1:(10-90)。Sample solution preparation process: Add the Pangasius extract into the container, and add the upper phase and lower phase of the TMBE-n-butanol-acetonitrile-water solvent system respectively to completely dissolve the sample; as an option, the added Pangasius extract should be in the same container as The volume ratio is 1: (10-90).

步骤4、高速逆流色谱分离Step 4. High-speed countercurrent chromatography separation

一维分离:采用六通阀,将六通阀一放置在溶剂瓶和泵之间,以方便在内循环和收集之间切换,并将六通阀二连接到六通阀一和检测器之间。本发明只用六通阀一来控制内循环;One-dimensional separation: Use a six-way valve, place the six-way valve one between the solvent bottle and the pump to facilitate switching between internal circulation and collection, and connect the six-way valve two to the six-way valve one and the detector. between. This invention only uses six-way valve one to control the internal circulation;

内循环分离:关闭六通阀收集模式以进入内循环逆流色谱法CCC分离过程;关闭六通阀一将洗脱液泵回柱,形成循环,在一个周期的第一个峰之后与另一个峰的末端峰重叠,将循环模式转换为正常洗脱法,采用逐次从头到尾的洗脱法避免峰顶重叠,以获得化合物。Internal loop separation: Close the six-way valve collection mode to enter the internal loop countercurrent chromatography CCC separation process; close the six-way valve and pump the eluent back to the column to form a cycle, with another peak after the first peak of a cycle If the terminal peaks overlap, switch the cycle mode to the normal elution method, and use the elution method from beginning to end to avoid overlapping of peaks to obtain the compound.

进一步的,步骤1中,所述岩七根茎,采用甲醇提取三次,将提取液合并,在减压和45℃条件浓缩,得到岩七的甲醇粗提物。Further, in step 1, the rhizome of Pangasius is extracted three times with methanol, the extracts are combined, and concentrated under reduced pressure and 45°C to obtain a crude methanol extract of Pangasius.

进一步的,步骤3中,所述TBME-正丁醇-乙腈-水的体积比为(1-5):(1-5):(0.5-3):(2-10),例如:所述体积比为2:2:1:5或3:1:1:5或1:3:1:5。Further, in step 3, the volume ratio of TBME-n-butanol-acetonitrile-water is (1-5): (1-5): (0.5-3): (2-10), for example: The volume ratio is 2:2:1:5 or 3:1:1:5 or 1:3:1:5.

进一步的,步骤4中,一维分离:以30mL/min首尾洗脱模式在CCC中泵入上相(固定相),在25℃条件下将CCC仪器转速调至800转/分钟,以2.0mL/min的速度泵入下相(流动相)直至平衡,从而获得适当的固定相保留值(Sf值)。平衡后进样,用便携式记录仪监测处于254nm波长的流出液;洗脱之前关闭内循环阀门。Further, in step 4, one-dimensional separation: Pump the upper phase (stationary phase) into the CCC in 30mL/min head-to-tail elution mode, adjust the CCC instrument speed to 800 rpm at 25°C, and use 2.0mL The lower phase (mobile phase) is pumped into the lower phase (mobile phase) at a speed of /min until equilibrium is achieved to obtain the appropriate stationary phase retention value (S f value). Inject the sample after equilibration, and use a portable recorder to monitor the effluent at a wavelength of 254 nm; close the internal circulation valve before elution.

进一步的,所述纯化物包括槲皮素-鼠李糖苷、槲皮素-3-O-鼠李糖苷、岩白菜素、山奈酚和棕榈酸。Further, the purified product includes quercetin-rhamnoside, quercetin-3-O-rhamnoside, fuscine, kaempferol and palmitic acid.

进一步的,样品进样后,通过六通阀一切换至循环模式,当特定目标峰达到分离则切换至正常模式,进行收集,收集完毕后切换至循环模式,进行其他成分内循环分离,重复上述步骤,完成化合物分离;所述化合物山奈酚和棕榈酸在第一次循环中洗脱得到,化合物岩白菜素在第二次循环中洗脱得到,化合物槲皮素-鼠李糖苷、槲皮素-3-O-鼠李糖苷在第四次循环中洗脱得到。Further, after the sample is injected, switch to the circulation mode through the six-way valve. When the specific target peak reaches separation, it switches to the normal mode and collects it. After the collection is completed, it switches to the circulation mode to perform internal circulation separation of other components. Repeat the above Steps to complete the separation of compounds; the compounds kaempferol and palmitic acid are eluted in the first cycle, the compound cobracine is eluted in the second cycle, and the compounds quercetin-rhamnoside, quercetin -3-O-rhamnoside eluted in the fourth cycle.

进一步的,所述制备方法采用内循环CCC系统,所述内循环CCC系统包括六通阀一、六通阀二、泵、溶剂瓶、进样器、逆流分离柱和检测器;所述六通阀一连接在溶剂瓶和泵之间,以方便在内循环和收集之间切换,所述六通阀二连接在六通阀一和检测器之间;所述泵与进样器连接,进样器与逆流分离柱连接,逆流分离柱与检测器连接,检测器与六通阀二连接,六通阀二与收集圈连接,六通阀一与馏出液管连接;关闭六通阀一将洗脱液泵回柱,形成循环Further, the preparation method adopts an internal circulation CCC system, which includes a six-way valve one, a six-way valve two, a pump, a solvent bottle, a sampler, a countercurrent separation column and a detector; the six-way Valve one is connected between the solvent bottle and the pump to facilitate switching between internal circulation and collection. The six-way valve two is connected between the six-way valve one and the detector; the pump is connected to the injector, and The sampler is connected to the counterflow separation column, the counterflow separation column is connected to the detector, the detector is connected to six-way valve two, six-way valve two is connected to the collection ring, six-way valve one is connected to the distillate pipe; close six-way valve one Pump the eluate back to the column to form a cycle

所述岩白菜属植物活性成分的制备方法所提取的化合物在医药领域中的应用。Application of the compounds extracted by the method for preparing active ingredients of Brassica genus plants in the medical field.

本发明的技术效果:Technical effects of the present invention:

与现有技术相比,本发明建立了一种有效的一步内循环CCC方法,可从巴基斯坦的岩七根茎中分离化合物。采用优化的双相溶剂体系(TBME/正丁醇/乙腈/水(2:2:1:5,v/v),成功分离了槲皮素-鼠李糖苷、槲皮素-3-O-鼠李糖苷、岩白菜素、山奈酚和棕榈酸5个化合物。所建立的一步内循环CCC方法适用于有相似KD值化合物的分离,具有溶剂用量少、耗时短、理论极板数高等优点。Compared with the existing technology, the present invention establishes an effective one-step internal circulation CCC method to isolate compounds from the rhizomes of Pangasius in Pakistan. Quercetin-rhamnoside and quercetin-3-O- were successfully separated using an optimized biphasic solvent system (TBME/n-butanol/acetonitrile/water (2:2:1:5, v/v) Five compounds: rhamnoside, cochinacein, kaempferol and palmitic acid. The established one-step internal cycle CCC method is suitable for the separation of compounds with similar K D values, and has the advantages of low solvent consumption, short time consumption, high number of theoretical plates High advantages.

附图说明Description of the drawings

图1为本发明岩七甲醇粗提物中分离化合物的化学结构图;Figure 1 is a chemical structure diagram of the isolated compounds in the crude petrous methanol extract of the present invention;

图2为本发明HSCCC分离模式示意图,其中,图2(A)为正常洗脱模式,图2(B)为内循环模式;Figure 2 is a schematic diagram of the HSCCC separation mode of the present invention, wherein Figure 2(A) is the normal elution mode, and Figure 2(B) is the internal circulation mode;

图3为本发明HSCCC内循环模式下化合物分离的色谱图;Figure 3 is a chromatogram of compound separation in the HSCCC internal circulation mode of the present invention;

图4为本发明岩七甲醇提取物的HPLC图谱。Figure 4 is an HPLC chromatogram of the methanol extract of Pangasius of the present invention.

图中,11、六通阀一;12、六通阀二;13、溶剂瓶;14、泵;15、检测器;16、进样器;17、逆流分离柱;18、馏出液管;19、收集圈。In the figure, 11. Six-way valve one; 12. Six-way valve two; 13. Solvent bottle; 14. Pump; 15. Detector; 16. Injector; 17. Countercurrent separation column; 18. Distillate pipe; 19. Collection circle.

具体实施方式Detailed ways

为使本发明实施例的目的、技术方案和优点更加清楚,下面结合说明书附图,对本发明实施例中的技术方案进行清楚、完整地描述。In order to make the purpose, technical solutions and advantages of the embodiments of the present invention more clear, the technical solutions in the embodiments of the present invention are clearly and completely described below in conjunction with the accompanying drawings.

实施例1:Example 1:

本实施例涉及一种岩白菜属植物活性成分的制备方法,从岩七根茎中提取化合物,其中,本实施例所述岩七产自巴基斯坦。This embodiment relates to a method for preparing active ingredients of the rock cabbage plant, extracting the compound from the rhizomes of rock seven, wherein the rock seven described in this embodiment is produced in Pakistan.

1.1试剂和材料1.1 Reagents and materials

分析级甲醇、叔丁基甲基醚(TBME)、正丁醇和乙腈用于提取和HSCCC分离,HPLC级乙腈用于HPLC,采用milli-Q(18MΩ)系统纯水。Analytical grade methanol, tert-butyl methyl ether (TBME), n-butanol and acetonitrile were used for extraction and HSCCC separation, HPLC grade acetonitrile was used for HPLC, and milli-Q (18MΩ) system pure water was used.

1.2设备1.2 Equipment

使用TBE-300C型HSCCC设备采用三个300毫升多层线圈分离柱和一个20毫升手动样品环进行分离。HSCCC设备配备了一台254nm的8823A-UV监视器、一台TBP-5002恒流量泵、一台3057型便携式记录仪以及一个用于保持恒温(25℃)的低温恒温浴。高效液相色谱设备是沃特斯600系统,包含一个PDA检测器15、一个沃特斯600泵以及一个自动进样器16,对称C18柱(250mm×4.6mm,i.d.5μm,USA)。使用安捷伦1100SL系列MSD Trap进行电喷雾串联质谱分析(ESI/MS),同时采用了电喷雾离子源MSD捕集器,使用Bruker Avance DRX-400记录核磁共振光谱。所有的化学变化用PPM表示为与内源对照物四甲基硅烷比较的δ值。Separation was performed using a model TBE-300C HSCCC device using three 300 ml multilayer coil separation columns and a 20 ml manual sample loop. The HSCCC equipment is equipped with a 254nm 8823A-UV monitor, a TBP-5002 constant flow pump, a Model 3057 portable recorder, and a cryogenic thermostatic bath to maintain a constant temperature (25°C). The HPLC equipment was a Waters 600 system, including a PDA detector 15, a Waters 600 pump and an autosampler 16, symmetrical C18 column (250 mm × 4.6 mm, i.d. 5 μm, USA). An Agilent 1100SL series MSD Trap was used for electrospray tandem mass spectrometry (ESI/MS). An electrospray ion source MSD trap was also used, and a Bruker Avance DRX-400 was used to record nuclear magnetic resonance spectra. All chemical changes are expressed in PPM as delta values compared to the endogenous control tetramethylsilane.

1.3所述制备方法包括:1.3 The preparation method includes:

步骤1、粗提物制备:将收集的植物根茎用胶带和蒸馏水冲洗,然后在阴凉处室温干燥;干燥根茎(2.0kg)用90%甲醇提取三次,将提取液合并,在减压和45℃条件浓缩,得到102g岩七的甲醇粗提物;Step 1. Preparation of crude extract: Rinse the collected plant rhizomes with tape and distilled water, and then dry them at room temperature in a cool place; extract the dried rhizomes (2.0kg) three times with 90% methanol, combine the extracts, and incubate under reduced pressure at 45°C. Conditions were concentrated to obtain 102g of crude methanol extract of Penthospermum;

步骤2、双相溶剂体系的选择:称重后取适量的样品放入10ml离心管中,平衡后的双相溶剂各取1ml放入离心管反复震荡,使样品完全分布在两相中,静置分为两层,每相加入1mL甲醇稀释,用HPLC分析;通过将固定相(下相,AL)的目标化合物峰面积除以流动相(上相,AU)的峰面积来计算KD值(KD=AL/AU);Step 2. Selection of biphasic solvent system: After weighing, take an appropriate amount of sample and put it into a 10ml centrifuge tube. Take 1ml of each balanced biphasic solvent and put it into the centrifuge tube and shake it repeatedly to make the sample completely distributed in the two phases. Set into two layers, add 1 mL of methanol to each phase to dilute, and analyze with HPLC; calculate K by dividing the peak area of the target compound in the stationary phase (lower phase, A L ) by the peak area of the mobile phase (upper phase, A U ) D value (K D = AL /A U );

步骤3、溶剂系统和样品溶液制备Step 3. Solvent system and sample solution preparation

HSCCC分离准备:在分液漏斗中加入含TBME-正丁醇-乙腈-水(2:2:1:5,v/v)的双相溶剂体系并对其进行剧烈震荡,静置15分钟至成两相平衡状态,上下相分别作为固定相和流动相;Preparation for HSCCC separation: Add a biphasic solvent system containing TBME-n-butanol-acetonitrile-water (2:2:1:5, v/v) into the separatory funnel and shake it vigorously, and let it stand for 15 minutes. into a two-phase equilibrium state, with the upper and lower phases serving as stationary phase and mobile phase respectively;

样品溶液准备过程:将280mg岩七提取物加入10ml离心管中,分别加入TMBE-正丁醇-乙腈-水(2:2:1:5,v/v)溶剂体系的5ml上相和5ml下相,使样品完全溶解;Sample solution preparation process: Add 280 mg of Pangasius extract into a 10 ml centrifuge tube, and add 5 ml of the upper phase and 5 ml of the lower phase of the TMBE-n-butanol-acetonitrile-water (2:2:1:5, v/v) solvent system. phase to completely dissolve the sample;

步骤4、高速逆流色谱分离Step 4. High-speed countercurrent chromatography separation

一维分离One-dimensional separation

采用能够实现内循环的六通阀,将六通阀一11放置在溶剂瓶13和泵14之间,以方便在内循环和收集之间切换,并将六通阀二12(由于不需要在外部柱中在线存储,因此关闭)连接到六通阀一11和检测器15之间(图2A);泵14与进样器16连接,进样器16与逆流分离柱17连接,逆流分离柱17与检测器15连接,检测器15与六通阀二12连接,六通阀二12与收集圈19连接,六通阀一11与馏出液管18连接。本发明只用六通阀一11来控制内循环。Use a six-way valve capable of internal circulation, place the six-way valve 11 between the solvent bottle 13 and the pump 14 to facilitate switching between internal circulation and collection, and place the six-way valve 212 (since there is no need to Online storage in the external column, therefore closed) is connected between the six-way valve 11 and the detector 15 (Fig. 2A); the pump 14 is connected to the injector 16, the injector 16 is connected to the countercurrent separation column 17, and the countercurrent separation column 17 is connected to the detector 15, the detector 15 is connected to the six-way valve 12, the six-way valve 12 is connected to the collection ring 19, and the six-way valve 11 is connected to the distillate pipe 18. The present invention only uses six-way valve 11 to control the internal circulation.

以30mL/min首尾洗脱模式在CCC中泵入上相(固定相),在25℃条件下将CCC仪器转速调至800转/分钟,以2.0mL/min的速度泵入下相(流动相)直至平衡,从而获得适当的固定相保留值(Sf值)。平衡后进样,用便携式记录仪监测处于254nm波长的流出液;洗脱之前关闭内循环阀门;样品进样后,通过六通阀一11切换至循环模式,当特定目标峰达到分离则切换至正常模式,进行收集,收集完毕后切换至循环模式,进行其他成分内循环分离,重复上述步骤,完成化合物分离;Pump the upper phase (stationary phase) into the CCC in head-to-tail elution mode at 30 mL/min, adjust the CCC instrument speed to 800 rpm at 25°C, and pump the lower phase (mobile phase) at a speed of 2.0 mL/min. ) until equilibrium is obtained to obtain the appropriate stationary phase retention value (S f value). Inject the sample after equilibrium, and use a portable recorder to monitor the effluent at a wavelength of 254 nm; close the internal circulation valve before elution; after the sample is injected, switch to the circulation mode through the six-way valve - 11, and switch to the circulation mode when the specific target peak reaches separation. In the normal mode, collect. After the collection is completed, switch to the circulation mode to perform internal circulation separation of other components. Repeat the above steps to complete the compound separation;

内循环分离Inner loop separation

关闭六通阀收集模式以进入内循环逆流色谱法CCC分离过程。关闭六通阀一11将洗脱液泵回柱,形成循环(如图2B),在一个周期的第一个峰之后与另一个峰的末端峰重叠,将循环模式转换为正常洗脱法,采用逐次从头到尾的洗脱法避免峰顶重叠,以获得纯化物;Close the six-way valve collection mode to enter the internal circulation countercurrent chromatography CCC separation process. Close the six-way valve 11 and pump the eluate back to the column to form a cycle (as shown in Figure 2B). After the first peak of a cycle overlaps with the end peak of another peak, convert the cycle mode to the normal elution method. Use a sequential elution method from beginning to end to avoid overlapping peaks to obtain purified products;

步骤5、HPLC分析及结构鉴定Step 5. HPLC analysis and structural identification

采用Water 600系统进行色谱分离,在柱温为25℃流速为1.0mL/min的条件下,用由水(A)和乙腈(B)组成的流动相以以下梯度洗脱柱:0-7min,90-70%A;7-12min,70-65%A;12-13min,65-90%A,13-20min,90%A。得到190~400nm处的光谱图,和254nm处的色谱图。A Water 600 system was used for chromatographic separation. At a column temperature of 25°C and a flow rate of 1.0 mL/min, the column was eluted with a mobile phase consisting of water (A) and acetonitrile (B) with the following gradient: 0-7 min, 90-70%A; 7-12min, 70-65%A; 12-13min, 65-90%A, 13-20min, 90%A. Obtain the spectrum at 190~400nm and the chromatogram at 254nm.

采用Agilent 6520 Q-TOF仪器(Agilent,Santa Clara,CA,USA)进行ESI-MS分析,以CD3OD为溶剂,采用Bruker Biospin(Rheinstetten,Germany)记录核磁共振光谱,用百万分率(ppm)加上常数(J)表示化学位移(δ),单位为Hz。ESI-MS analysis was performed using an Agilent 6520 Q-TOF instrument (Agilent, Santa Clara, CA, USA), CD 3 OD was used as the solvent, and NMR spectra were recorded using Bruker Biospin (Rheinstetten, Germany), expressed in parts per million (ppm). ) plus a constant (J) represents the chemical shift (δ) in Hz.

1.4结果与讨论1.4 Results and discussion

1.4.1双相溶剂体系的选择1.4.1 Selection of biphasic solvent system

使用HSCCC分离时选择合适的双相溶剂体系非常重要,合适的溶剂应具有合适的分配系数和较好的样品溶解度。本实施例考察了几种混合溶剂体系,其中包括乙酸乙酯/正丁醇/水(4:1:5,v/v),正己烷/乙酸乙酯/甲醇/水(0.5:4.5:0.5:4.5,v/v),氯仿/甲醇/水(5:2:3,v/v)与TBME/正丁醇/乙腈/水(2:2:1:5,v/v)(表1)。如果使用乙酸乙酯/正丁醇/水(4:1:5,v/v)和正己烷/乙酸乙酯/甲醇/水(0.5:4.5:0.5:4.5,v/v),则这些化合物主要分布在上相,KD值大、增加了洗脱的难度。如果使用氯仿/甲醇/水(5:2:3,v/v),则化合物主要在下相分布,这会导致洗脱速度快并且峰值分辨率低。It is very important to choose an appropriate biphasic solvent system when using HSCCC separation. The appropriate solvent should have an appropriate distribution coefficient and good sample solubility. This example examined several mixed solvent systems, including ethyl acetate/n-butanol/water (4:1:5, v/v), n-hexane/ethyl acetate/methanol/water (0.5:4.5:0.5 :4.5, v/v), chloroform/methanol/water (5:2:3, v/v) and TBME/n-butanol/acetonitrile/water (2:2:1:5, v/v) (Table 1 ). If ethyl acetate/n-butanol/water (4:1:5, v/v) and n-hexane/ethyl acetate/methanol/water (0.5:4.5:0.5:4.5, v/v) are used, these compounds Mainly distributed in the upper phase, the K D value is large, which increases the difficulty of elution. If chloroform/methanol/water (5:2:3, v/v) is used, the compounds are mainly distributed in the lower phase, which results in fast elution and low peak resolution.

TBME/正丁醇/乙腈/水溶剂体系用于分离中等至高极性的化合物,在溶剂体系中由于增加乙腈与TBME的比例会导致三相形成,因此电位比受到限制。当使用TBME/正丁醇/乙腈/水(1:3:1:5,v/v)和(2:3:0:5,v/v)溶剂体系时,峰洗脱开始很晚,有的峰没有得到很好的洗脱。使用TBME/正丁醇/乙腈/水(3:1:1:5,v/v)溶剂体系时化合物1和2的KD值较小表示峰值分辨率差。与测试的溶剂体系相比TBME/正丁醇/乙腈/水(2:2:1:5,v/v)在0.87~1.79范围内为宜(表1),化合物1、2的分配系数与化合物3、4、5的分配系数相比小于1.50。分配系数低表明传统的一步分离技术难以分离这些化合物,因此本实施例在HSCCC采用了内循环模式。The TBME/n-butanol/acetonitrile/water solvent system is used to separate compounds of moderate to high polarity. In the solvent system, increasing the ratio of acetonitrile to TBME will lead to the formation of three phases, so the potential ratio is limited. When using TBME/n-butanol/acetonitrile/water (1:3:1:5, v/v) and (2:3:0:5, v/v) solvent systems, peak elution starts very late, with The peaks were not eluted well. The smaller K D values of compounds 1 and 2 when using the TBME/n-butanol/acetonitrile/water (3:1:1:5, v/v) solvent system indicate poor peak resolution. Compared with the tested solvent system, TBME/n-butanol/acetonitrile/water (2:2:1:5, v/v) is preferably in the range of 0.87 to 1.79 (Table 1). The distribution coefficients of compounds 1 and 2 are The partition coefficients of compounds 3, 4, and 5 are less than 1.50. The low distribution coefficient indicates that it is difficult to separate these compounds by traditional one-step separation technology, so this example adopts the internal circulation mode in HSCCC.

表1化合物的在逆流色谱溶剂系统中的分配系数Table 1 Distribution coefficients of compounds in countercurrent chromatography solvent systems

1.4.2化学成分分离1.4.2 Separation of chemical components

在常规HSCCC中采用TBME/正丁醇/乙腈/水溶剂体系(2:2:1:5,v/v),样品负载为280mg,化合物3、4和5在第一步分离时可分离,但分离率较差(图3),本实验将化合物进行循环,得到了较好的分离率。在第一次循环中,化合物4(37mg)和5(43mg)有合适的KD值而被洗脱得到,经HPLC分析,其纯度均大于98%,该方法的独特之处是在第一个循环中分离两个纯的化合物。如果化合物4和5在第一次循环中未被洗脱得到,化合物将进入第二次循环,然后化合物可以相互合并,这增加了分离的复杂性。因此化合物4和5在第一次循环中洗脱得到,化合物3(76mg)在第二次循环中洗脱得到,化合物1(33mg)和2(36mg)在第四次循环中洗脱得到是最合适的分离方案。根据HPLC分析,这些化合物的纯度高于98%(图4)。Using TBME/n-butanol/acetonitrile/water solvent system (2:2:1:5, v/v) in conventional HSCCC with a sample load of 280 mg, compounds 3, 4 and 5 could be separated in the first step of separation. However, the separation rate is poor (Figure 3). In this experiment, the compound was recycled and a better separation rate was obtained. In the first cycle, compounds 4 (37 mg) and 5 (43 mg) were eluted with appropriate K D values. After HPLC analysis, their purity was greater than 98%. The uniqueness of this method is that in the first cycle Two pure compounds are separated in this cycle. If compounds 4 and 5 are not eluted in the first cycle, the compounds will enter the second cycle, and then the compounds can merge with each other, which increases the complexity of the separation. Therefore, compounds 4 and 5 eluted in the first cycle, compound 3 (76 mg) eluted in the second cycle, and compounds 1 (33 mg) and 2 (36 mg) eluted in the fourth cycle. The most suitable separation solution. According to HPLC analysis, the purity of these compounds was greater than 98% (Figure 4).

1.4.3内循环逆流色谱程序1.4.3 Internal circulation countercurrent chromatography program

色谱分离的基本方程是分离时的分辨率、理论板数和柱长之间的关系。The basic equation of chromatographic separation is the relationship between resolution, number of theoretical plates and column length during separation.

(R1/R2)2=N1/N2=L1/L2 (R 1 /R 2 ) 2 =N 1 /N 2 =L 1 /L 2

R表示分辨率,N表示理论总板数,L表示柱长。CCC柱越长表示理论板数越大、拥有较好的分离率。与HPLC相比HSCCC的理论板数较少,因此CCC分离的价值较低,然而通过对经典HSCCC方法中的内循环进行微调,可以提高其价值,这使得在植物化学分离中分离KD值相近的相对复杂的化合物成为可能。R represents the resolution, N represents the total theoretical number of plates, and L represents the column length. The longer the CCC column, the greater the number of theoretical plates and better separation rate. HSCCC has fewer theoretical plates compared to HPLC, so the value of CCC separations is lower, however its value can be increased by fine-tuning the inner loop in the classic HSCCC method, which results in similar separation K D values in phytochemical separations relatively complex compounds are possible.

内循环CCC模式的一个循环的最后一个峰与第二个循环的第一个峰重叠,化合物在第2次循环开始重叠,纯化合物被洗脱。在第一次循环中连续洗脱两个化合物,在第二次和第三次循环中连续洗脱一个化合物,有助于分离纯化合物。与传统的长时间洗脱工艺相比,循环模式在溶剂用量和时间消耗方面具有优势,它提高了理论板数N、提高了峰值分辨率、设置简单、易于操作。In the internal cycle CCC mode, the last peak of one cycle overlaps with the first peak of the second cycle. Compounds begin to overlap in the second cycle and pure compounds are eluted. Sequential elution of two compounds in the first cycle and one compound in the second and third cycles facilitates the isolation of pure compounds. Compared with the traditional long-time elution process, the circulation mode has advantages in terms of solvent usage and time consumption. It increases the number of theoretical plates N, improves peak resolution, is simple to set up, and is easy to operate.

1.4.4结构鉴定1.4.4 Structural identification

槲皮素-鼠李糖苷(1):ESI-MS(正离子模式)m/z 773.0314[M+H]+,1H-NMR(400MHz,DMSO-d6):δH 6.21(1H,d,arom,H-6),6.43(1H,d,arom,H-8),7.70(1H,d,arom,H-2’),6.87(IH,d,H-5’),7.63(1H,dd,arom,H-6’),5.09(1H,d,H-1”),3.47(1H,m,H-2”),3.39(1H,m,3”),3.38(1H,m,4”),3.35(1H,m,5”),3.77(1H,dd,H-6”A),3.79(1H,m,H-6”B),4.55(1H,dd,1”’),3.93(1H,dd,H-2”’),3.60(1H,dd,H-3”’),3.46(1H,m,H-4”’),3.52(1H,dd,H-5”’),1.11(1H,d,H-6”’),4.41(1H,d,H-1””),3.27(1H,m,H-2””),3.40(1H,m,H-3””),3.40(1H,m,H-4””),3.23(1H,m,H-5””),3.71(1H,dd,H-6””).13C-NMR(100MHz DMSO-d6):δC160.3(C-2),135.3(C-3),180.0(C-4),162.3(C-5),100.3(C-6),166.0(C-7),95.1(C-8),159.0(C-9),104.7(C-10),122.6(C-1’),118.2(C-2’),145.6(C-3’),150.0(C-4’),115.6(C-5’),123.6(C-6’),105.3(C-1”),76.0(C-2”),77.0(C-3”),72.0(C-4”),78.5(C-5”),69.3(C-6”),101.8(C-1”’),70.8(C-2”’),83.0(C-3”’),72.0(C-4”’),69.5(C-5”’),17.8(C-6”’),105.6(C-1””),75.6(C-2””),77.6(C-3””),71.0(C-4””),77.6(C-5””),62.0(C-6””)。Quercetin-rhamnoside (1): ESI-MS (positive ion mode) m/z 773.0314[M+H] + , 1 H-NMR (400MHz, DMSO-d 6 ): δ H 6.21 (1H,d ,arom,H-6),6.43(1H,d,arom,H-8),7.70(1H,d,arom,H-2'),6.87(IH,d,H-5'),7.63(1H ,dd,arom,H-6'),5.09(1H,d,H-1”),3.47(1H,m,H-2”),3.39(1H,m,3”),3.38(1H,m ,4”),3.35(1H,m,5”),3.77(1H,dd,H-6”A),3.79(1H,m,H-6”B),4.55(1H,dd,1”'),3.93(1H,dd,H-2”'),3.60(1H,dd,H-3”’),3.46(1H,m,H-4”’),3.52(1H,dd,H-5”'),1.11(1H,d,H-6”’),4.41(1H,d,H-1””),3.27(1H,m,H-2””),3.40(1H,m,H -3””),3.40(1H,m,H-4””),3.23(1H,m,H-5””),3.71(1H,dd,H-6””). 13 C-NMR( 100MHz DMSO-d 6 ): δ C 160.3(C-2), 135.3(C-3), 180.0(C-4), 162.3(C-5), 100.3(C-6), 166.0(C-7) ,95.1(C-8),159.0(C-9),104.7(C-10),122.6(C-1'),118.2(C-2'),145.6(C-3'),150.0(C- 4'),115.6(C-5'),123.6(C-6'),105.3(C-1”),76.0(C-2”),77.0(C-3”),72.0(C-4” ),78.5(C-5”),69.3(C-6”),101.8(C-1”’),70.8(C-2”’),83.0(C-3”’),72.0(C-4 ”'),69.5(C-5”’),17.8(C-6”’),105.6(C-1””),75.6(C-2””),77.6(C-3””),71.0 (C-4””),77.6(C-5””),62.0(C-6””).

槲皮素-3-O-鼠李糖苷(2):ESI-MS(负离子模式)m/z 608.0820[M-H]-,ESI-MS(positive ion mode)m/z 611.1618[M+H]+.1H-NMR(400MHz,CD3OD):δH 6.22(1H,d,H-6),6.41(1H,d,H-8),7.67(1H,d,H-2’),6.88(1H,d,H-5’),7.63(1H,dd,H-6’),5.11(1H,d,H-1”),3.26-3.48(4H,m,H-2”,H-3”,H-4”,H-5”),3.39(1H,m,Ha-6”),4.52(1H,d,H-1”’),3.63(1H,dd,H-2”’),3.54(1H,dd,H-3’”),3.27(1H,m,H-4”’),3.44(1H,m,H-5”’),3.81(1H,dt,Hb-6”).13C-NMR(CD3OD,100MHz):δC 158.69(C-2),136.72(C-3),179.61(C-4),162.17(C-5),100.10(C-6),167.19(C-7),95.01(C-8),159.51(C-9),106.06(C-10),123.30(C-1’),117.84(C-2’),146.02(C-3’),150.45(C-4’),116.22(C-5’),123.70(C-6’),104.85(C-1”),75.90(C-2”),77.41(C-3”),71.57(C-4”),78.36(C-5”),68.72(C-6”),102.58(C-1”’),72.27(C-2”’),72.41(C-3’”),74.10(C-4”’),70.59(C-5”’),18.03(C-6”’)[32]。Quercetin-3-O-rhamnoside (2): ESI-MS (negative ion mode) m/z 608.0820[MH] - , ESI-MS (positive ion mode) m/z 611.1618[M+H] + . 1 H-NMR (400MHz, CD 3 OD): δ H 6.22(1H,d,H-6),6.41(1H,d,H-8),7.67(1H,d,H-2'),6.88( 1H,d,H-5'),7.63(1H,dd,H-6'),5.11(1H,d,H-1”),3.26-3.48(4H,m,H-2”,H-3 ”,H-4”,H-5”),3.39(1H,m,Ha-6”),4.52(1H,d,H-1”’),3.63(1H,dd,H-2”’) ,3.54(1H,dd,H-3'"),3.27(1H,m,H-4"'),3.44(1H,m,H-5"'),3.81(1H,dt,Hb-6" ). 13 C-NMR (CD 3 OD, 100MHz): δ C 158.69 (C-2), 136.72 (C-3), 179.61 (C-4), 162.17 (C-5), 100.10 (C-6) ,167.19(C-7),95.01(C-8),159.51(C-9),106.06(C-10),123.30(C-1'),117.84(C-2'),146.02(C-3 '),150.45(C-4'),116.22(C-5'),123.70(C-6'),104.85(C-1”),75.90(C-2”),77.41(C-3”) ,71.57(C-4”),78.36(C-5”),68.72(C-6”),102.58(C-1”’),72.27(C-2”’),72.41(C-3’” ),74.10(C-4”’),70.59(C-5”’),18.03(C-6”’)[32].

岩白菜素(3):ESI-MS(正离子模式)m/z 773.0314[M+H]+,1H-NMR(400MHz,DMSO-d6):δH 7.08(1H,m,arom,7-H),4.95(1H,dd,H-4a),4.05(1H,dd,H-4),4.01(3H,s,H-12),3.80(2H,d,H-11),3.76(2H,m),3.66(1H,m,H-2),3.45(1H,dd,H-3).13C-NMR(100MHz DMSO-d6):δC 164.4(C-6),150.9(C-8),148.0(C-10),140.9(C-9),118.0(C-6a),115.9(C-10a),109.7(C-7),81.6(C-2),80.0(C-4a),74.2(C-4),72.9(C-10b),70.5(C-3),61.3(C-11),59.5(C-12)[33]。Brassin (3): ESI-MS (positive ion mode) m/z 773.0314[M+H] + , 1 H-NMR (400MHz, DMSO-d 6 ): δ H 7.08 (1H,m,arom,7 -H),4.95(1H,dd,H-4a),4.05(1H,dd,H-4),4.01(3H,s,H-12),3.80(2H,d,H-11),3.76( 2H,m),3.66(1H,m,H-2),3.45(1H,dd,H-3). 13 C-NMR(100MHz DMSO-d 6 ): δ C 164.4(C-6),150.9( C-8),148.0(C-10),140.9(C-9),118.0(C-6a),115.9(C-10a),109.7(C-7),81.6(C-2),80.0(C -4a),74.2(C-4),72.9(C-10b),70.5(C-3),61.3(C-11),59.5(C-12)[33].

山奈酚(4):ESI-MS(负离子模式)m/z 285.2310[M-H]-.1H-NMR(400MHz,DMSO):δH6.19(1H,d,arom,H-6),6.44(1H,d,arom,H-8),8.04(1H,d,arom,H-2',6'),6.92(1H,d,arom,H-3',5').13C-NMR(100MHz DMSO):δC146.9(C-2),135.7(C-3),176.0(C-4),160.8(C-5),98.3(C-6),164.0(C-7),93.6(C-8),156.3(C-9),103.1(C-10),121.8(C-1′),129.6(C-2',6'),115.5(C-3',5'),159.3(C-4')[34]。Kaempferol (4): ESI-MS (negative ion mode) m/z 285.2310[MH] - . 1 H-NMR (400MHz, DMSO): δ H 6.19 (1H, d, arom, H-6), 6.44 (1H ,d,arom,H-8),8.04(1H,d,arom,H-2',6'),6.92(1H,d,arom,H-3',5'). 13 C-NMR(100MHz DMSO): δ C 146.9(C-2),135.7(C-3),176.0(C-4),160.8(C-5),98.3(C-6),164.0(C-7),93.6(C -8),156.3(C-9),103.1(C-10),121.8(C-1′),129.6(C-2',6'),115.5(C-3',5'),159.3( C-4')[34].

棕榈酸(5):ESI-MS(正离子模式)m/z 256.4321[M+H]+.1H-NMR(400MHz,DMSO-d6):δH 0.93(3H,t,H-16),1.25(24H,m,H-4to H-15),1.50(2H,H-3),2.20(2H,H-2).13C-NMR(100MHz DMSO-d6):δC 174.5(C-1),33.7(C-2),31.3-24.5(5signals C-3 to C-14),22.1(C-15),13.9(C-16)[32]。Palmitic acid (5): ESI-MS (positive ion mode) m/z 256.4321[M+H] + . 1 H-NMR (400MHz, DMSO-d 6 ): δ H 0.93 (3H,t,H-16) ,1.25(24H,m,H-4to H-15),1.50(2H,H-3),2.20(2H,H-2). 13 C-NMR(100MHz DMSO-d 6 ): δ C 174.5(C -1),33.7(C-2),31.3-24.5(5signals C-3 to C-14),22.1(C-15),13.9(C-16)[32].

本发明建立了一种有效的一步内循环CCC方法,可从巴基斯坦的岩七根茎中分离化合物。采用优化的双相溶剂体系(TBME/正丁醇/乙腈/水(2:2:1:5,v/v),成功分离了槲皮素-鼠李糖苷(1)、槲皮素-3-O-鼠李糖苷(2)、岩白菜素(3)、山奈酚(4)和棕榈酸(5)五个化合物,纯度均>98%(如图1所示)。所建立的一步内循环CCC方法适用于有相似KD值化合物的分离,具有溶剂用量少、耗时短、理论极板数N高等优点。所述方法也适用于从其他天然衍生产物中分离类似KD值的化合物。The present invention establishes an effective one-step internal circulation CCC method to isolate compounds from Pangasius rhizome in Pakistan. Quercetin-rhamnoside (1) and quercetin-3 were successfully separated using an optimized biphasic solvent system (TBME/n-butanol/acetonitrile/water (2:2:1:5, v/v) Five compounds -O-rhamnoside (2), fucocyanin (3), kaempferol (4) and palmitic acid (5), the purity is >98% (as shown in Figure 1). The established one-step The cyclic CCC method is suitable for the separation of compounds with similar K D values, and has the advantages of less solvent consumption, short time consumption, and a high theoretical plate number N. The method is also suitable for the separation of compounds with similar K D values from other naturally derived products. compound.

上述具体实施方式仅是本发明的具体个案,本发明的专利保护范围包括但不限于上述具体实施方式,任何符合本发明权利要求书且任何所属技术领域的普通技术人员对其所做的适当变化或修饰,皆应落入本发明的专利保护范围。The above-mentioned specific embodiments are only specific cases of the present invention. The patent protection scope of the present invention includes but is not limited to the above-mentioned specific embodiments, any appropriate changes made to them by those of ordinary skill in the technical field that are consistent with the claims of the present invention. or modifications shall fall within the scope of patent protection of the present invention.

Claims (10)

1. A preparation method of bergenia plant active ingredient is characterized in that: comprising the following steps:
step 1, preparing a crude extract: extracting rhizoma corydalis Decumbentis with methanol, mixing the extractive solutions, and concentrating to obtain crude methanol extract of rhizoma corydalis Decumbentis;
step 2, selecting a biphasic solvent system: taking a methanol crude extract samplePlacing into a container, adding balanced biphasic solvent, repeatedly oscillating to make the sample completely distributed in two phases, standing to separate into two layers, and adding methanol into each layer for dilution; by bringing the lower phase into stationary phase A L Dividing the peak area of the target compound by the phase-mobile phase A U Calculation of K by peak area D Value: k (K) D =A L /A U
Step 3, solvent System and sample solution preparation
Hscc separation preparation: adding a biphasic solvent system containing TBME-n-butanol-acetonitrile-water into a separating funnel, vigorously oscillating, standing until the two phases are in a balanced state, wherein an upper phase and a lower phase are respectively used as a stationary phase and a mobile phase;
sample solution preparation process: adding the radix Notoginseng extract into a container, and respectively adding upper phase and lower phase of TMBE-n-butanol-acetonitrile-water solvent system to dissolve the sample completely;
step 4, high-speed countercurrent chromatographic separation
One-dimensional separation: a six-way valve is adopted, a first six-way valve is arranged between the solvent bottle and the pump, and a second six-way valve is connected between the first six-way valve and the detector; the internal circulation is controlled by a six-way valve I;
and (3) internal circulation separation: closing a six-way valve collection mode to enter an internal circulation countercurrent chromatography CCC separation process; and closing the six-way valve, returning the eluent pump to the column to form a cycle, overlapping the tail end peak of the first peak and the tail end peak of the other peak in one cycle, converting the cycle mode into a normal elution method, and adopting a sequential elution method from beginning to end to avoid overlapping peak tops so as to obtain the compound.
2. The method for preparing an active ingredient of bergenia plants according to claim 1, wherein: in the step 1, extracting the rhizome of the radix cynanchi with methanol for three times, combining the extracting solutions, and concentrating under reduced pressure at 45 ℃ to obtain a crude methanol extract of the radix cynanchi.
3. The method for preparing an active ingredient of bergenia plants according to claim 1, wherein: in the step 3, the volume ratio of TBME-n-butanol-acetonitrile-water is (1-5): (1-5): (0.5-3):
(2-10)。
4. the method for preparing an active ingredient of bergenia plants according to claim 1, wherein: in the step 3, the volume ratio of TBME-n-butanol-acetonitrile-water is 2:2:1:5.
5. The method for preparing an active ingredient of bergenia plants according to claim 1, wherein: in the step 3, the volume ratio of TBME-n-butanol-acetonitrile-water is 3:1:1:5 or 1:3:1:5.
6. the method for preparing an active ingredient of bergenia plants according to claim 1, wherein: in step 4, one-dimensional separation: pumping the upper phase-stationary phase into CCC in 30mL/min head-tail elution mode, adjusting CCC instrument rotation speed to 800 rpm at 25deg.C, pumping the lower phase-mobile phase at 2.0mL/min until equilibrium, thereby obtaining proper stationary phase retention value S f A value; sampling after balancing, and monitoring effluent liquid at 254nm wavelength by using a portable recorder; the internal circulation valve was closed prior to elution.
7. The method for preparing an active ingredient of bergenia plants according to claim 1, wherein: the purified product comprises quercetin-rhamnoside, quercetin-3-O-rhamnoside, bergenin, kaempferol and palmitic acid.
8. The method for preparing an active ingredient of bergenia plants according to claim 1, wherein: after sample injection, switching to a circulation mode through a six-way valve, switching to a normal mode when a target peak is separated, collecting, switching to the circulation mode after collection is finished, carrying out internal circulation separation of other components, and repeating the steps to finish compound separation; the compounds kaempferol and palmitic acid are eluted in the first circulation, the compounds bergenin is eluted in the second circulation, and the compounds quercetin-rhamnoside and quercetin-3-O-rhamnoside are eluted in the fourth circulation.
9. A process for the preparation of bergenia plant active ingredient according to any one of claims 1 to 8, characterized in that: an internal circulation CCC system is adopted, and comprises a six-way valve I, a six-way valve II, a pump, a solvent bottle, a sample injector, a countercurrent separation column and a detector; the first six-way valve is connected between the solvent bottle and the pump so as to be convenient for switching between internal circulation and collection, and the second six-way valve is connected between the first six-way valve and the detector; the pump is connected with the sample injector, the sample injector is connected with the countercurrent separation column, the countercurrent separation column is connected with the detector, the detector is connected with the six-way valve II, the six-way valve II is connected with the collecting ring, and the six-way valve I is connected with the distillate pipe.
10. Use of a compound extracted by the method for preparing an active ingredient of bergenia plants according to any one of claims 1 to 8 in the pharmaceutical field.
CN202311059234.9A 2023-08-22 2023-08-22 Preparation method and application of bergenia plant active ingredient Pending CN117362307A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202311059234.9A CN117362307A (en) 2023-08-22 2023-08-22 Preparation method and application of bergenia plant active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202311059234.9A CN117362307A (en) 2023-08-22 2023-08-22 Preparation method and application of bergenia plant active ingredient

Publications (1)

Publication Number Publication Date
CN117362307A true CN117362307A (en) 2024-01-09

Family

ID=89393601

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202311059234.9A Pending CN117362307A (en) 2023-08-22 2023-08-22 Preparation method and application of bergenia plant active ingredient

Country Status (1)

Country Link
CN (1) CN117362307A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119144624A (en) * 2024-09-10 2024-12-17 云南农业大学 Asparagus carboxyglycosyltransferase ApCGT gene and application thereof in preparation of bergenin

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060045926A1 (en) * 2004-09-02 2006-03-02 Marcel Nimni Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin
CN108226358A (en) * 2018-03-09 2018-06-29 山东省分析测试中心 For the multidimensional counter-current chromatograph and method of work of complex sample multi-cycle separation
CN110272433A (en) * 2018-08-12 2019-09-24 长沙爱扬医药科技有限公司 A method of extracting quercitrin and Bergenin
CN111808150A (en) * 2020-08-25 2020-10-23 山东省分析测试中心 Method for large-scale separation of compounds from rock cabbage and detection method for antioxidant activity

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060045926A1 (en) * 2004-09-02 2006-03-02 Marcel Nimni Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin
CN108226358A (en) * 2018-03-09 2018-06-29 山东省分析测试中心 For the multidimensional counter-current chromatograph and method of work of complex sample multi-cycle separation
CN110272433A (en) * 2018-08-12 2019-09-24 长沙爱扬医药科技有限公司 A method of extracting quercitrin and Bergenin
CN111808150A (en) * 2020-08-25 2020-10-23 山东省分析测试中心 Method for large-scale separation of compounds from rock cabbage and detection method for antioxidant activity

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BRUCE A. BOHM ET AL.: ""Flavonoids of Some Species of Bergenia, Francoa, Parnassia and Lepuropetalon"", 《BIOCHEMICAL SYSTEMATICS AND ECOLOGY》, vol. 14, no. 1, 31 December 1986 (1986-12-31), pages 75 - 77 *
孙佳月: ""厚叶岩白菜化学成分研究及其对小鼠脾淋巴细胞转化的影响"", 《中国优秀硕士学位论文全文数据库医药卫生科技辑》, no. 12, 15 December 2021 (2021-12-15) *
徐巧琳: ""厚叶岩白菜化学成分研究"", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》, no. 3, 15 March 2019 (2019-03-15) *
杨琳 等: ""岩白菜的化学成分及利用价值研究概况"", 《四川林业科技》, vol. 44, no. 2, 30 April 2023 (2023-04-30), pages 8 - 12 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119144624A (en) * 2024-09-10 2024-12-17 云南农业大学 Asparagus carboxyglycosyltransferase ApCGT gene and application thereof in preparation of bergenin

Similar Documents

Publication Publication Date Title
Yao et al. Preparative isolation and purification of chemical constituents from the root of Polygonum multiflorum by high-speed counter-current chromatography
CN104031013B (en) A kind of utilize the isolated and purified method preparing salvianolic acid B and rosmarinic acid of high speed adverse current chromatogram
CN113105388B (en) A kind of diterpenoid compound and its extraction method and application
CN102351824B (en) Method for preparing lactuca indica and lactucin
CN101343225A (en) Preparation method for high-purity di-coffee mesitoyl quinine acid compounds
CN108707133B (en) Lignans compound, and method and application for extracting and separating lignans compound from eagle tea
Bakri et al. Separation and purification of two new and two known alkaloids from leaves of Nitraria sibirica by pH-zone-refining counter-current chromatography
CN106866609B (en) A kind of preparation method and application of noval chemical compound in Sabia parviflora Wall.ex Roxb
CN110452113A (en) A kind of (4 → 2) rearranged Crotane type diterpenoids and its preparation method and application
CN117362307A (en) Preparation method and application of bergenia plant active ingredient
CN104262154A (en) Preparation method for polyphenol monomers from gnaphlium affine
CN108689851A (en) A kind of tigliane type diterpene compound and its preparation method and application
CN108912049A (en) The Diterpenoid Alkaloids compound and preparation method and application extracted from the high rhizome of Chinese monkshood
CN105294722B (en) A kind of preparation method of high-purity glabrene monomer
CN109705077B (en) Coumarin compound and preparation method and application thereof
CN102532147B (en) Preparation method of high purity dictamnine monomer
CN1307191C (en) Method for preparing geniposide and genipin-1-β-D-gentiobioside from gardenia fruit
Lu et al. Efficient counter-current chromatographic isolation and structural identification of two new cinnamic acids from Echinacea purpurea
CN114262294B (en) A kind of phenylisoquinoline alkaloid compound and its preparation method and application
CN111909228B (en) Alkaloid compound and preparation method and application thereof
Yu et al. A strategy based on isocratic and linear-gradient high-speed counter-current chromatography for the comprehensive separation of platycosides from Platycodi radix
CN110204589B (en) Active ingredients, extraction method and application in the preparation of neuroprotective drugs
WO2017215679A2 (en) Pharmaceutical composition of chlorambucil and medical use thereof to counter depression
CN101362768A (en) Separation and purification method of monomer compound in Angelica dahurica
CN119504900B (en) Phenylpropanoid compound and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination